Huntington National Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.9M Buy
360,484
+227,219
+171% +$13.2M 0.12% 152
2025
Q4
$7.19M Sell
133,265
-5,918
-4% -$285K 0.04% 216
2025
Q3
$6.28M Sell
139,183
-14,648
-10% -$684K 0.04% 234
2025
Q2
$7.12M Sell
153,831
-4,989
-3% -$245K 0.05% 219
2025
Q1
$9.69M Sell
158,820
-5,708
-3% -$333K 0.07% 189
2024
Q4
$9.31M Sell
164,528
-14
-0% -$782 0.07% 192
2024
Q3
$8.51M Sell
164,542
-1,707
-1% -$80.1K 0.06% 201
2024
Q2
$6.9M Sell
166,249
-14,681
-8% -$657K 0.05% 216
2024
Q1
$9.81M Sell
180,930
-22,411
-11% -$1.14M 0.08% 185
2023
Q4
$10.4M Sell
203,341
-14,911
-7% -$783K 0.09% 182
2023
Q3
$12.7M Sell
218,252
-11,710
-5% -$718K 0.13% 154
2023
Q2
$14.7M Buy
229,962
+1,796
+0.8% +$120K 0.14% 153
2023
Q1
$15.8M Sell
228,166
-19,578
-8% -$1.38M 0.16% 138
2022
Q4
$17.8M Sell
247,744
-5,335
-2% -$402K 0.19% 125
2022
Q3
$18M Sell
253,079
-5,594
-2% -$406K 0.21% 116
2022
Q2
$19.9M Sell
258,673
-3,405
-1% -$259K 0.21% 117
2022
Q1
$19.1M Sell
262,078
-5,961
-2% -$400K 0.18% 123
2021
Q4
$16.7M Sell
268,039
-11,222
-4% -$658K 0.15% 138
2021
Q3
$16.5M Sell
279,261
-5,406
-2% -$356K 0.17% 134
2021
Q2
$19M Buy
284,667
+22,211
+8% +$1.45M 0.19% 120
2021
Q1
$16.6M Sell
262,456
-8,745
-3% -$544K 0.2% 119
2020
Q4
$16.8M Sell
271,201
-8,773
-3% -$539K 0.22% 113
2020
Q3
$16.9M Sell
279,974
-7,687
-3% -$463K 0.25% 107
2020
Q2
$16.9M Sell
287,661
-17,707
-6% -$1.06M 0.27% 99
2020
Q1
$17M Sell
305,368
-12,476
-4% -$763K 0.32% 89
2019
Q4
$20.4M Buy
317,844
+2,993
+1% +$171K 0.31% 95
2019
Q3
$16M Sell
314,851
-20,339
-6% -$956K 0.26% 107
2019
Q2
$15.2M Sell
335,190
-31,548
-9% -$1.47M 0.24% 115
2019
Q1
$17.5M Sell
366,738
-21,762
-6% -$1.08M 0.29% 106
2018
Q4
$20.2M Sell
388,500
-34,683
-8% -$1.86M 0.36% 92
2018
Q3
$26.3M Sell
423,183
-30,053
-7% -$1.78M 0.41% 79
2018
Q2
$25.1M Sell
453,236
-53,149
-10% -$2.87M 0.42% 72
2018
Q1
$32M Sell
506,385
-34,764
-6% -$2.24M 0.53% 59
2017
Q4
$33.2M Sell
541,149
-47,076
-8% -$2.94M 0.53% 59
2017
Q3
$37.5M Sell
588,225
-66,039
-10% -$3.86M 0.63% 44
2017
Q2
$36.5M Sell
654,264
-40,750
-6% -$2.22M 0.64% 44
2017
Q1
$37.8M Sell
695,014
-175,408
-20% -$9.62M 0.67% 40
2016
Q4
$50.9M Sell
870,422
-178,218
-17% -$9.74M 0.92% 19
2016
Q3
$56.5M Buy
1,048,640
+243,995
+30% +$15.7M 1.05% 18
2016
Q2
$59.2M Buy
804,645
+78,905
+11% +$5.58M 1.48% 6
2016
Q1
$46.8M Sell
725,740
-37,877
-5% -$2.39M 1.14% 11
2015
Q4
$52.5M Buy
763,617
+70,380
+10% +$4.65M 1.33% 10
2015
Q3
$41M Sell
693,237
-552
-0.1% -$35K 1.08% 15
2015
Q2
$46.2M Sell
693,789
-31,951
-4% -$2.11M 1.12% 12
2015
Q1
$46.8M Sell
725,740
-69,577
-9% -$4.36M 1.14% 11
2014
Q4
$46.9M Sell
795,317
-24,177
-3% -$1.36M 1.12% 13
2014
Q3
$41.9M Sell
819,494
-53,828
-6% -$2.69M 0.86% 18
2014
Q2
$42.4M Buy
873,322
+51,811
+6% +$2.55M 0.84% 18
2014
Q1
$42.7M Buy
821,511
+15,394
+2% +$819K 0.82% 18
2013
Q4
$42.8M Buy
806,117
+4,394
+0.5% +$224K 1.13% 12
2013
Q3
$37.1M Sell
801,723
-19,886
-2% -$873K 1.11% 13
2013
Q2
$36.7M Buy
+821,609
New +$35.7M 1.14% 13

Other funds holding BMY

Huntington National Bank's BMY Position: Q1 2026 in Review

Huntington National Bank increased its Bristol-Myers Squibb (BMY) stake by 171% in Q1 2026, buying an estimated $13.2M and bringing the position to 360,484 shares worth $21.9M. The position accounts for 0.12% of the portfolio, ranked #152.

Huntington National Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $59.2M in Q2 2016. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Huntington National Bank held 360,484 shares of Bristol-Myers Squibb worth $21.9M as of Q1 2026.
  • Huntington National Bank bought 227,219 Bristol-Myers Squibb shares in Q1 2026, an estimated $13.2M.
  • Bristol-Myers Squibb made up 0.12% of Huntington National Bank's portfolio in Q1 2026, its #152 holding.
  • Huntington National Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Huntington National Bank's Bristol-Myers Squibb position peaked at $59.2M in Q2 2016.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.